Mytos

About:

Mytos is building a fully-automated cell manufacture platform for Pharma

Twitter/X: mytosbio

Top Investors: Y Combinator, Wing Venture Capital, Charlie Songhurst, IQ Capital, Acequia Capital (AceCap)

Description:

Mytos is building a fully-automated cell manufacturing platform for biotech, starting with the drug development industry

Total Funding Amount:

$20.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2018-01-01

Founders:

Ali Afshar, Ignacio Willats

Number of Employees:

11-50

Last Funding Date:

2023-11-30

IPO Status:

Private

Industries: